CSE: BUX | OTCQB: BMKDF

BioMark™ Diagnostics

Wolverton Securities advisor believes in biotechnology

Santo Sandhu, an investment advisor with Wolverton Securities, said he believes the best opportunities right now lie in biotechnology.

That has led him to BioMark Diagnostics Inc., a Richmond B.C. company that is developing a cancer diagnostic system, using a known drug, which has already been approved by the U.S. Federal Drug Administration and Health Canada.

With phase 3 clinical trials under way in Bangladesh and Manitoba, Canada, the company has seen its stock price jump to $1.02 from 44 cents in early November.
Read more at http://www.stockhouse.com

Contact BioMark Diagnostics

Canadian Stock Exchange

CSE: BUX
BioMark Diagnostics Inc.
$0.55
+0.00 (0.00%)
Last updated: Market close • Delayed quote
View Live Quote on Yahoo Finance →

OTC Markets

OTCQB: BMKDF
BioMark Diagnostics Inc.
$0.40
+0.00 (0.00%)
Last updated: Market close • Delayed quote
View Live Quote on Yahoo Finance →

Frankfurt Stock Exchange

FSE: 20B
BioMark Diagnostics Inc.
€0.36
+0.00 (0.00%)
Last updated: Market close • Delayed quote
View Live Quote on Yahoo Finance →

Share This Post

Facebook
X
LinkedIn
Reddit
VK
StumbleUpon
Telegram
XING
WhatsApp
Threads
Email
Print

Related News

Sign up for the latest BioMark news